Document is current
Any future updates will be listed below
-
Authors
Freyvert, Yevgeniy
Yong, Nicholas Au
Morikawa, Erika
Zdunowski, Sharon
Sarino, Melanie E.
Gerasimenko, Yury
Edgerton, V. Reggie
Lu, Daniel C.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR000124)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (EB15521)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (EB15521)
U.S. Department of Health & Human Services | NIH | NICHD | National Center for Medical Rehabilitation Research (EB15521)
- License Information
-
More Information
Article History
Received: 13 June 2018
Accepted: 17 September 2018
First Online: 19 October 2018
Competing Interests
: D.C.L., V.R.E., and Y.G. have ownership interest in NeuroEnabling Technologies, which develops the transcutaneous stimulator to improve motor function to address paralysis.
